224 related articles for article (PubMed ID: 25747107)
1. Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.
Herrera-Carrillo E; Harwig A; Berkhout B
RNA Biol; 2015; 12(4):447-56. PubMed ID: 25747107
[TBL] [Abstract][Full Text] [Related]
2. Influence of the loop size and nucleotide composition on AgoshRNA biogenesis and activity.
Herrera-Carrillo E; Harwig A; Berkhout B
RNA Biol; 2017 Nov; 14(11):1559-1569. PubMed ID: 28569591
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights on the Dicer-independent AGO2-mediated processing of AgoshRNAs.
Liu YP; Karg M; Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen A; Berkhout B
RNA Biol; 2015; 12(1):92-100. PubMed ID: 25826416
[TBL] [Abstract][Full Text] [Related]
4. The influence of the 5΄-terminal nucleotide on AgoshRNA activity and biogenesis: importance of the polymerase III transcription initiation site.
Herrera-Carrillo E; Gao ZL; Harwig A; Heemskerk MT; Berkhout B
Nucleic Acids Res; 2017 Apr; 45(7):4036-4050. PubMed ID: 27928054
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HIV-1 by AgoshRNA molecules.
Herrera-Carrillo E; Harwig A; Berkhout B
Gene Ther; 2017 Aug; 24(8):453-461. PubMed ID: 28553929
[TBL] [Abstract][Full Text] [Related]
6. Boosting AgoshRNA activity by optimized 5'-terminal nucleotide selection.
Gao Z; Berkhout B; Herrera-Carrillo E
RNA Biol; 2019 Jul; 16(7):890-898. PubMed ID: 30991896
[TBL] [Abstract][Full Text] [Related]
7. Analysis of AgoshRNA maturation and loading into Ago2.
Harwig A; Kruize Z; Yang Z; Restle T; Berkhout B
PLoS One; 2017; 12(8):e0183269. PubMed ID: 28809941
[TBL] [Abstract][Full Text] [Related]
8. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
Berkhout B; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
[TBL] [Abstract][Full Text] [Related]
9. Towards Antiviral shRNAs Based on the AgoshRNA Design.
Liu YP; Karg M; Herrera-Carrillo E; Berkhout B
PLoS One; 2015; 10(6):e0128618. PubMed ID: 26087209
[TBL] [Abstract][Full Text] [Related]
10. Probing the shRNA characteristics that hinder Dicer recognition and consequently allow Ago-mediated processing and AgoshRNA activity.
Herrera-Carrillo E; Harwig A; Liu YP; Berkhout B
RNA; 2014 Sep; 20(9):1410-8. PubMed ID: 25035295
[TBL] [Abstract][Full Text] [Related]
11. Dicer-independent processing of short hairpin RNAs.
Liu YP; Schopman NC; Berkhout B
Nucleic Acids Res; 2013 Apr; 41(6):3723-33. PubMed ID: 23376931
[TBL] [Abstract][Full Text] [Related]
12. Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.
Herrera-Carrillo E; Gao Z; Berkhout B
Mol Ther Nucleic Acids; 2019 Jun; 16():452-462. PubMed ID: 31048184
[TBL] [Abstract][Full Text] [Related]
13. Deep Sequence Analysis of AgoshRNA Processing Reveals 3' A Addition and Trimming.
Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen AH; Berkhout B
Mol Ther Nucleic Acids; 2015 Jul; 4(7):e247. PubMed ID: 26172504
[TBL] [Abstract][Full Text] [Related]
14. Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects.
Shang R; Zhang F; Xu B; Xi H; Zhang X; Wang W; Wu L
Nat Commun; 2015 Oct; 6():8430. PubMed ID: 26455506
[TBL] [Abstract][Full Text] [Related]
15. Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.
Hagopian JC; Hamil AS; van den Berg A; Meade BR; Eguchi A; Palm-Apergi C; Dowdy SF
Nucleic Acid Ther; 2017 Oct; 27(5):260-271. PubMed ID: 28933656
[TBL] [Abstract][Full Text] [Related]
16. DICER-ARGONAUTE2 complex in continuous fluorogenic assays of RNA interference enzymes.
Bernard MA; Wang L; Tachado SD
PLoS One; 2015; 10(3):e0120614. PubMed ID: 25793518
[TBL] [Abstract][Full Text] [Related]
17. Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing.
Dallas A; Ilves H; Ge Q; Kumar P; Shorenstein J; Kazakov SA; Cuellar TL; McManus MT; Behlke MA; Johnston BH
Nucleic Acids Res; 2012 Oct; 40(18):9255-71. PubMed ID: 22810205
[TBL] [Abstract][Full Text] [Related]
18. Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes.
Kim K; Lee YS; Carthew RW
RNA; 2007 Jan; 13(1):22-9. PubMed ID: 17123955
[TBL] [Abstract][Full Text] [Related]
19. Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection.
Herrera-Carrillo E; Berkhout B
PLoS One; 2017; 12(5):e0177935. PubMed ID: 28542329
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
